Temporal trends and hierarchical disparities of antibiotic utilization patterns:A longitudinal analysis in Shanghai,20172024OA
Antimicrobial resistance(AMR)is a critical public health threat.As a densely populated megacity,Shanghai exhibits complex patterns of antibiotic consumption.This study evaluated temporal trends and hierarchical disparities in antibiotic use across Shanghai''s public hospitals(2017-2024)to inform targeted stewardship.Antibiotics were classified and quantified using the Anatomical Therapeutic Chemical/Defined Daily Dose(ATC/DDD)methodology.Comparative analyses were conducted across hospital tiers for the following metrics:DDDs,DDDs per 1000 inhabitants per day(DID),daily dose cost(DDC),and proportions of broad-spectrum antibiotics and parenteral formulations.Temporal trends were evaluated using compound annual growth rate(CAGR).From 2017 to 2024,public hospitals in Shanghai procured 257 distinct antimicrobial agents.DDDs demonstrated an initial decline followed by an increase,representing an overall reduction of 29.42%(CAGR=-4.86%).Meanwhile,DID fell by 29.90%(CAGR=-4.95%),with seasonal peaks in January,September,and December.Notably,the proportion of J01D antibiotics decreased by 35.78%,and the proportion of broad-spectrum anti-biotic use rose from 74.47%to 78.40%(CAGR=0.74%).Parenteral antibiotic use dropped substantially from 58.81%to 25.47%(CAGR=-11.27%),while its share of total expenditure remained high at 75%-80%.Considerable heterogeneity was observed across hospital levels:secondary and tertiary hospitals showed de-clining DDDs,the greatest reductions in parenteral and broad-spectrum antibiotic use,and increasing DDC,whereas primary hospitals had relatively stable utilization and lower DDC.Policy-related analyses indicated that National Essential Medicines List(NEML)drugs maintained lower DDC than non-NEML drugs but had a de-clining utilization share,while NRDL drugs increased their shares in both use and expenditure.Overall,total antibiotic consumption and the proportion of parenteral formulations in Shanghai have declined;however,the persistently high proportion of broad-spectrum antibiotics highlights ongoing challenges in antibiotic stew-ardship.Significant disparities across hospital tiers emphasize the need for tier-specific strategies and enhanced diagnostic precision to mitigate resistance.
Rui Huang;Biao Wang;Qianqian Yu;Qingwei Tang;Junyu Niu;Li Luo
Shanghai Institute of Infectious Disease and Biosecurity,Fudan University,Shanghai,200032,ChinaSchool of Public Health,Fudan University,Shanghai,200032,ChinaSchool of Public Health,Fudan University,Shanghai,200032,ChinaSchool of Public Health,Fudan University,Shanghai,200032,ChinaSchool of Public Health,Fudan University,Shanghai,200032,ChinaShanghai Institute of Infectious Disease and Biosecurity,Fudan University,Shanghai,200032,China
医药卫生
AntibioticutilizationPublichospitalsPharmaceuticalpolicyChina
《Pharmacoeconomics and Policy》 2026 (2)
P.100-109,10
funded by the National Natural Science Foundation of China Scientists Fund(Grant No.:72174041).
评论